SoRI-9804
SoRI-9804 is a chemical compound that acts as a selective dopamine receptor modulator. It is primarily used in research settings to study the effects of dopamine receptor modulation on various physiological and neurological processes.
Chemical Properties[edit]
SoRI-9804 is a synthetic compound with a complex chemical structure, as depicted in the adjacent image. It is classified as a dopamine receptor ligand, meaning it binds to dopamine receptors in the brain and modulates their activity.
Mechanism of Action[edit]
SoRI-9804 functions by selectively modulating the activity of dopamine receptors, particularly the D2 and D3 subtypes. Unlike typical dopamine receptor agonists or antagonists, SoRI-9804 exhibits a unique profile that allows it to fine-tune receptor activity without fully activating or blocking the receptor. This makes it a valuable tool for studying the nuanced roles of dopamine in the central nervous system.
Research Applications[edit]
In research, SoRI-9804 is used to explore the role of dopamine in various neurological and psychiatric conditions, such as Parkinson's disease, schizophrenia, and addiction. By modulating dopamine receptor activity, researchers can gain insights into the pathophysiology of these conditions and evaluate potential therapeutic strategies.
Pharmacological Effects[edit]
The pharmacological effects of SoRI-9804 are primarily observed in the central nervous system. It has been shown to influence neurotransmitter release, neuronal excitability, and synaptic plasticity. These effects are crucial for understanding how dopamine modulates brain function and behavior.
Related Pages[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
